COVID-19 Manufacturing for Monoclonal Antibodies (Updated August 2020)

covid

Policy Brief

COVID-19 Manufacturing for Monoclonal Antibodies (Updated August 2020)

Published date

June 22, 2020

Duke-Margolis Authors

Kroetsch

Adam Kroetsch, MPP

Research Director, Biomedical Innovation and Regulatory Policy
Senior Team Member

Mark McClellan

Mark McClellan, MD, PhD

Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty